| EPA074 | Youth HIV-associated neurocognitive disorders: a longitudinal cohort study | E-poster | HIV and co-morbidities |
| EPA075 | What can we learn from the 2021 Aids Healthcare Foundation-Eswatini mortality profile after meeting the UNAIDS 95-95-95 target? | E-poster | HIV and co-morbidities |
| EPA077 | Active tuberculosis co-infection is associated with broad HIV-1 antibody responses | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA078 | Role of PD-1, TIGIT and TIM3 on NK cell exhaustion and function in HIV/HCV coinfection, and the impact of HCV elimination in the long term | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA079 | Maternal HIV status and risk of infant M. tuberculosis infection | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA080 | Impact of chronic HCV infection on CD4-T cells permissiveness to HIV infection and viral reservoir persistence | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA081 | HPV circulating tumoural DNA as a potential biomarker to monitor anal lesions in HIV-infected men who have sex with men (MSM) | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA082 | Machine learning prediction and phyloanatomic modeling of viral neuroadaptive signatures in the macaque model of human immunodeficiency virus-mediated neuropathology | E-poster | Neuropathogenesis |
| EPA083 | Evidence of recurrent selection of mutations commonly found in SARS-CoV-2 variants of concern in viruses infecting immunocompromised patients | E-poster | SARS-Cov2 Viral origins, evolution and diversity |
| EPA084 | Effects of COVID-19 on the cytokine background in chronic controlled HIV infection | E-poster | Immune responses to SARS-Cov2 |